If you're exploring ways to take variability out of your operation without slowing it down, let's connect so we can share what we're seeing across different compounding pharmacy models
Additionally, after 40 weeks in SURPASS-2, individuals treated with tirzepatide exhibited lower triglyceride levels, ranging from 19.0% to 24.8%, in comparison to semaglutide 1 mg, which showed an 11.5% reduction
Instead, pharmacists follow strict guidelines set by the United States Pharmacopeia (USP), specifically USP for sterile compounding, to determine a safe BUD
For more information on the analysis and sources, refer to the Methodology section
o RYBELSUS (formulation R1) includes strengths 3 mg, 7 mg and 14 mg